Status:
RECRUITING
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
Lead Sponsor:
University of Minnesota
Conditions:
Insulin Resistance
Fasting
Eligibility:
All Genders
18-65 years
Brief Summary
This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.
Detailed Description
There is potential benefit to prolonged water fasting, fasting with ad libitum water intake and consciously eating little to no food or caloric beverages, with regards to reducing weight, fat mass, in...
Eligibility Criteria
Inclusion
- Ages of 18-65 years old
- Not pregnant
- No comorbid conditions
- BMI of 18.5-29.9.
- Has a smartphone
Exclusion
- Concern for active eating disorder per screening questionnaire
- Self-reported eating disorder or history of eating disorder
- History of hypoglycemia or contraindication for Prolonged Fasting
- Weight \<120lbs
- History of blood donation within the last 3 months.
Key Trial Info
Start Date :
August 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07216989
Start Date
August 5 2025
End Date
October 1 2026
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455